Author: Wang, Ting; Yin, Huiquan; Li, Yan; Zhao, Lingxiao; Sun, Xiahui; Cong, Hua
Title: Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes Document date: 2017_4_3
ID: 1ay8y7li_46
Snippet: In summary, mucosal immunization with recombinant adenovirus vaccine expressing ubiquitin-conjugated multistage antigen segments (Ad-UMAS) is a potential vaccination route to elicit protective immune responses. Compared to other immunization routes, oral and nasal immunizations with Ad-UMAS elicit both robust systemic and mucosal immune responses, accompanied by a significant increase in survival rates after challenge with highly virulent parasit.....
Document: In summary, mucosal immunization with recombinant adenovirus vaccine expressing ubiquitin-conjugated multistage antigen segments (Ad-UMAS) is a potential vaccination route to elicit protective immune responses. Compared to other immunization routes, oral and nasal immunizations with Ad-UMAS elicit both robust systemic and mucosal immune responses, accompanied by a significant increase in survival rates after challenge with highly virulent parasites and a dramatic reduction in brain cyst burdens in vaccinated mice after challenge with mild strains of T. gondii. Therefore, the results of this study should contribute to the development of an effective and safe mucosal vaccine for preventing T. gondii infection.
Search related documents:
Co phrase search for related documents- adenovirus vaccine and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- adenovirus vaccine and immunization route: 1, 2
- adenovirus vaccine and mucosal immunization: 1, 2, 3
- adenovirus vaccine and mucosal vaccine: 1, 2, 3, 4, 5, 6, 7, 8
- adenovirus vaccine and recombinant adenovirus vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- adenovirus vaccine and significant increase: 1, 2, 3, 4
- adenovirus vaccine and study result: 1
- adenovirus vaccine and survival rate: 1
- adenovirus vaccine and vaccination route: 1, 2
- antigen segment and immune response: 1
- brain cyst and gondii infection: 1, 2, 3
- brain cyst and immune response: 1, 2
- brain cyst and nasal oral immunization: 1
- brain cyst and significant increase: 1
- brain cyst and survival rate: 1
- brain cyst burden and gondii infection: 1
- brain cyst burden and nasal oral immunization: 1
- brain cyst burden and survival rate: 1
- dramatic reduction and immune response: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date